Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
TMO 596.92 +3.13(0.53%)
Will TMO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for TMO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TMO
MYGN Taps Ultima Genomics' UG 100 Platform for Advanced Clinical Tests
Danaher to Benefit From Business Strength Amid Headwinds
TMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
TMO's New ICP-MS Systems Boost Trace Element Analysis: Stock to Gain?
Should You Continue to Hold TMO Stock in Your Portfolio?
Other News for TMO
Dividend Champion, Contender, And Challenger Highlights: Week Of October 13
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
TMO November 29th Options Begin Trading
CURE: A Leveraged ETF To Own Throughout This Century
Thermo Fisher Scientific (TMO) Sees Stock Surge Amid Strong Financials